Mathias Schmidt

Title: Mathias Schmidt: Innovator in Antibody Development

Introduction

Mathias Schmidt is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of 2 patents, his work focuses on innovative solutions for diagnosing and treating pathological conditions.

Latest Patents

Schmidt's latest patents include advancements in epidermal growth factor receptor antibodies. The present invention relates to single and double chain antibodies to the EGF receptor. Additionally, it encompasses toxin conjugates of such antibodies. These antibodies are particularly useful for treating and diagnosing the status of pathological conditions such as cancer and cellular hyperproliferation. Another patent focuses on growth factor receptor antibodies, which shares similar applications and benefits.

Career Highlights

Throughout his career, Mathias Schmidt has worked with prominent companies, including Schering Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in antibody development and biotechnology.

Collaborations

Some of his notable coworkers include Winfried S. Wels and Evangelia Vakalopoulou. Their collaborative efforts have contributed to advancements in the field of antibody research.

Conclusion

Mathias Schmidt's innovative work in antibody development has the potential to significantly impact the medical field, particularly in cancer treatment and diagnosis. His contributions continue to pave the way for future advancements in biotechnology.